Immuneering (IMRX) EBIT Margin (2020 - 2022)
Immuneering (IMRX) recorded quarterly EBIT Margin of 3073627.91% in Q4 2022, down 8844.84% quarter-over-quarter from 34362.04% in Q3 2022, and down 306776489.0% on a YoY basis from N/an in Q4 2021.
Immuneering (IMRX) EBIT Margin (2020 - 2022) Analysis & Trends
Immuneering's EBIT Margin history runs 3 years deep, the most recent figure standing at 3073627.91% for Q4 2022.
- In Q4 2022, EBIT Margin fell 306776489.0% year-over-year to 3073627.91%; the TTM figure through Sep 2023 stood at 12328770.77% (down 1231911324.0% YoY), while the FY2022 annual figure was 16325.77%, down 1469661.0% from the prior year.
- EBIT Margin was 3073627.91% for Q4 2022 at Immuneering, down from 34362.04% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 644.66% in Q3 2020 to a low of 3073627.91% in Q4 2022.
- Historically, EBIT Margin has averaged 285392.02% across 3 years, with a median of 1772.01% in 2021.
- The sharpest annual moves came in 2021 and 2022: EBIT Margin sank 46060 bps in 2021, then tumbled 306776489 bps in 2022.
- A 3-year view of EBIT Margin shows it stood at 877.56% in 2020, then sank by 568 bps to 5863.02% in 2021, then plunged by 52324 bps to 3073627.91% in 2022.
- The last three EBIT Margin figures came in at 3073627.91% (Q4 2022), 34362.04% (Q3 2022), and 12334.43% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3,073,627.91% |
| Sep 30, 2022 | -34,362.04% |
| Jun 30, 2022 | -12,334.43% |
| Mar 31, 2022 | -7,036.37% |
| Dec 31, 2021 | -5,863.02% |
| Sep 30, 2021 | -1,772.01% |
| Jun 30, 2021 | -1,210.67% |
| Mar 31, 2021 | -833.47% |
| Dec 31, 2020 | -877.56% |
| Sep 30, 2020 | -644.66% |
| Jun 30, 2020 | -750.08% |